Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01396408
Title A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors NCIC Clinical Trials Group
Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST